HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leo Heunks Selected Research

Monoclonal Antibodies

12/2020Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leo Heunks Research Topics

Disease

10Critical Illness (Critically Ill)
01/2023 - 10/2018
8Respiratory Insufficiency (Respiratory Failure)
03/2023 - 03/2016
7COVID-19
01/2024 - 12/2020
4Atrophy
01/2023 - 12/2017
4Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
02/2022 - 01/2019
3Patient-Ventilator Asynchrony
12/2020 - 10/2017
2Pulmonary Edema
01/2023 - 02/2022
2Inflammation (Inflammations)
01/2023 - 12/2020
2Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 07/2011
2Heart Failure
11/2019 - 11/2016
1Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2023
1Neuroinflammatory Diseases
01/2023
1Necrosis
01/2023
1Pneumonia (Pneumonitis)
12/2020
1Dyspnea (Shortness of Breath)
12/2020
1Cough
01/2020
1Body Weight (Weight, Body)
01/2019
1Respiratory Acidosis
01/2019
1Muscular Atrophy (Muscle Atrophy)
12/2017
1Low Cardiac Output
11/2016
1Emphysema
07/2011

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2023
2Imatinib Mesylate (Gleevec)FDA Link
01/2023 - 02/2022
2ChemokinesIBA
01/2023 - 01/2021
2CytokinesIBA
01/2023 - 01/2021
2Neuromuscular Blocking AgentsIBA
07/2022 - 12/2020
2Complement System Proteins (Complement)IBA
01/2021 - 12/2020
2Simendan (Levosimendan)IBA
11/2019 - 11/2016
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2017 - 07/2011
1procollagen Type III-N-terminal peptide (PIIP)IBA
11/2023
1ThrombomodulinIBA
01/2023
1Triggering Receptor Expressed on Myeloid Cells-1IBA
01/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1LigandsIBA
01/2021
1AnaphylatoxinsIBA
12/2020
1Oxygen (Dioxygen)IBA
12/2020
1vilobelimabIBA
12/2020
1Monoclonal AntibodiesIBA
12/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2019
1UlaritideIBA
11/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
12/2017
1Peptide Hydrolases (Proteases)FDA Link
12/2017
1EnzymesIBA
12/2017
1CalpainIBA
12/2017
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2017
1UbiquitinIBA
12/2017
1calpeptinIBA
12/2017
1calpain inhibitorsIBA
12/2017
1Pancreatic Elastase (Elastase)IBA
07/2011
1Bortezomib (Velcade)FDA Link
07/2011
1Contractile ProteinsIBA
07/2011

Therapy/Procedure

13Artificial Respiration (Mechanical Ventilation)
03/2023 - 10/2018
6Mechanical Ventilators (Ventilator)
10/2021 - 10/2017
4Critical Care (Surgical Intensive Care)
03/2023 - 01/2020
2Catheters
01/2023 - 02/2022
2Cannula
10/2022 - 01/2022
2Ventilator Weaning
10/2021 - 01/2020
1Length of Stay
02/2022
1Contraindications
01/2022
1Therapeutics
11/2019
1Tracheostomy
01/2019
1Interactive Ventilatory Support
03/2016